Three young investigators from around Australia shared their research on testosterone, osteoarthritis, and medication-related osteonecrosis of the jaw (MRONJ) at the Amgen One conference in Melbourne. Findings from the CHAMP study Dr Ben Hsu, from the ANZAC Research Institute, School of Public Health, University of Sydney and Concord Hospital, presented findings from the Concord Health ...
The Young Investigator Series: Scrutinising testosterone, osteoarthritis, and osteonecrosis of the jaw
18 Apr 2019
Sponsored by Amgen Australia Pty Ltd